Fingerprint
Dive into the research topics of 'Cabazitaxel as second-line or third-line therapy in patients with metastatic castration-resistant prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cabazitaxel as second-line or third-line therapy in patients with metastatic castration-resistant prostate cancer
Per Kongsted, Inge M Svane, Henriette Lindberg, Rasmus Bisbjerg, Gedske Daugaard, Lisa Sengeløv